$GRVE
Groove Botanicals Inc

2024 Q4 Form 10-Q Financial Statement

#000117152024000360 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $18.33K
YoY Change -5.67%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $29.83K
YoY Change 19.78%
Operating Profit -$29.83K
YoY Change 19.78%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$29.83K
YoY Change 8.86%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 59.64M shares 59.64M shares
Diluted Shares Outstanding 59.64M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $6.133K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $4.992K
Receivables
Other Receivables
Total Short-Term Assets $11.13K
YoY Change 245.18%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $11.13K
Total Long-Term Assets $0.00
Total Assets $11.13K
YoY Change 245.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $947.3K
YoY Change 47.49%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $947.3K
Total Long-Term Liabilities
Total Liabilities $947.3K
YoY Change 47.49%
SHAREHOLDERS EQUITY
Retained Earnings -$35.02M
YoY Change 1.13%
Common Stock $59.64K
YoY Change 1.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$936.2K
YoY Change
Total Liabilities & Shareholders Equity $11.13K
YoY Change 245.18%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$29.83K
YoY Change 8.86%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity File Number
EntityFileNumber
000-23476
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21852 usd
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2142 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18332 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Entity Central Index Key
EntityCentralIndexKey
0000918573
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
usd
CY2024Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
usd
CY2024Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
usd
CY2023Q3 grve Consulting Expense
ConsultingExpense
usd
CY2024Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
grve Stock Issued For Outside Services
StockIssuedForOutsideServices
usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
GROOVE BOTANICALS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-1168832
dei Entity Address Address Line1
EntityAddressAddressLine1
310 Fourth Avenue South
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 7000
dei Entity Address City Or Town
EntityAddressCityOrTown
Minneapolis
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55415
dei City Area Code
CityAreaCode
612
dei Local Phone Number
LocalPhoneNumber
315-5068
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
59643062 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6133 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1688 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4992 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
454 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
11125 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
2142 usd
CY2024Q3 us-gaap Assets
Assets
11125 usd
CY2024Q1 us-gaap Assets
Assets
2142 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
74614 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
91172 usd
CY2024Q3 grve Related Party Payable Current
RelatedPartyPayableCurrent
544970 usd
CY2024Q1 grve Related Party Payable Current
RelatedPartyPayableCurrent
453057 usd
CY2024Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
267705 usd
CY2024Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
178470 usd
CY2024Q3 grve Dividend Payable Related Parties
DividendPayableRelatedParties
60000 usd
CY2024Q1 grve Dividend Payable Related Parties
DividendPayableRelatedParties
40000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
947289 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
762699 usd
CY2024Q3 us-gaap Liabilities
Liabilities
947289 usd
CY2024Q1 us-gaap Liabilities
Liabilities
762699 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59643062 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59643062 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59643062 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59643062 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
59643 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
59643 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
34026869 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
34026869 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-35022884 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-34847277 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-936164 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-760557 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11125 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
34931 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
38816 usd
CY2024Q3 grve Rent
Rent
3591 usd
CY2023Q3 grve Rent
Rent
4644 usd
grve Rent
Rent
8235 usd
grve Rent
Rent
9288 usd
CY2024Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
7410 usd
CY2023Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
1298 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
21956 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
25368 usd
CY2024Q3 grve Consulting Expense
ConsultingExpense
500 usd
grve Consulting Expense
ConsultingExpense
1250 usd
grve Consulting Expense
ConsultingExpense
78300 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
29833 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
27795 usd
us-gaap Operating Expenses
OperatingExpenses
66372 usd
us-gaap Operating Expenses
OperatingExpenses
151772 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-29833 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-27795 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-66372 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-151772 usd
CY2023Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2250 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
4500 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2250 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4500 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-29833 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-30045 usd
us-gaap Net Income Loss
NetIncomeLoss
-66372 usd
us-gaap Net Income Loss
NetIncomeLoss
-156272 usd
CY2024Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
54618 usd
CY2023Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
54618 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
109235 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
109235 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-84452 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-84663 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-175607 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-265507 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59643062 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59643062 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58643062 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58643062 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59643062 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59643062 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58561905 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58561905 shares
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-760557 usd
CY2024Q2 grve Accrued Dividend To Related Party
AccruedDividendToRelatedParty
-54617 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-36539 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-851713 usd
CY2024Q3 grve Accrued Dividend To Related Party Series Preferred Stock
AccruedDividendToRelatedPartySeriesPreferredStock
-10000 usd
CY2024Q3 grve Accrued Dividend To Series B Preferred Stock
AccruedDividendToSeriesBPreferredStock
-44618 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-29833 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-936164 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-438298 usd
CY2023Q2 grve Issuance Of Stock For Consulting
IssuanceOfStockForConsulting
78300 usd
CY2023Q2 grve Accrued Dividend To Related Party
AccruedDividendToRelatedParty
-54618 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-126227 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-540843 usd
CY2023Q3 grve Accrued Dividend To Related Party Series Preferred Stock
AccruedDividendToRelatedPartySeriesPreferredStock
-10000 usd
CY2023Q3 grve Accrued Dividend To Series B Preferred Stock
AccruedDividendToSeriesBPreferredStock
-44617 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-30045 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-625505 usd
us-gaap Net Income Loss
NetIncomeLoss
-66372 usd
us-gaap Net Income Loss
NetIncomeLoss
-156272 usd
grve Stock Issued For Outside Services
StockIssuedForOutsideServices
-78300 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-4500 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
24000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
24000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
4538 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-88 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-16558 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1438 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-63468 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-50822 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
67913 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
49102 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
67913 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
49102 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
4445 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1720 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1688 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4566 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6133 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2846 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_zDKnDBgFKBf7" style="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"><span id="xdx_86B_zDy50CALg2la">Use of Estimates</span></p> <p style="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman,serif; margin: 0 1.3pt 0 0; text-align: justify; text-indent: -0.45pt">The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Specifically, such estimates were made by the Company for the valuation of derivative liability, stock compensation and beneficial conversion feature expenses. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman,serif; margin: 0 1.3pt 0 0; text-align: justify; text-indent: -0.45pt"> </p>
us-gaap Net Income Loss
NetIncomeLoss
-66372 usd
us-gaap Net Income Loss
NetIncomeLoss
-156272 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-35022884 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-34847277 usd
CY2024Q3 grve Related Party Payment Outstanding
RelatedPartyPaymentOutstanding
544970 usd
CY2024Q1 grve Related Party Payment Outstanding
RelatedPartyPaymentOutstanding
453057 usd
CY2024Q3 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
500000 usd
CY2024Q3 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
5000
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59643062 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59643062 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59643062 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59643062 shares
grve Verbal Lease Agreement Description
VerbalLeaseAgreementDescription
Company has a month-to-month verbal lease agreement with the landlord, in which the Company pays $1,200 on a monthly basis.
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001171520-24-000360-index-headers.html Edgar Link pending
0001171520-24-000360-index.html Edgar Link pending
0001171520-24-000360.txt Edgar Link pending
0001171520-24-000360-xbrl.zip Edgar Link pending
eps11602_grve.htm Edgar Link pending
ex31.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
grve-20240930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
grve-20240930_cal.xml Edgar Link unprocessable
grve-20240930_def.xml Edgar Link unprocessable
grve-20240930_lab.xml Edgar Link unprocessable
eps11602_grve_htm.xml Edgar Link completed
grve-20240930_pre.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending